Management of Salivary Gland Malignancy: ASCO Guideline

With regards to systemic therapy, addition of concurrent chemotherapy may not be routinely offered outside of trial to patients undergoing adjuvant radiotherapy (RT) or RT for nonoperable tumour. Likewise for adjuvant endocrine/targeted therapy for AR and/or HER2-Neu tumours.

Journal of Clinical Oncology